• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Outcome of infants with acute lymphoblastic leukemia treated with the Chinese Children's Cancer Group Acute Lymphoblastic Leukemia 2015 study protocol.

作者信息

Leung Alex W K, Cai Jiaoyang, Wan Zhi, Qin Jiefen, Fang Yongjun, Sun Lirong, Zhu Jiashi, Hu Shaoyan, Wang Ningling, Gao Pan, Tian Xin, Zhu Xiaofan, Zhou Fen, Wu Xuedong, Ju Xiuli, Zhai Xiaowen, Jiang Hua, Hu Qun, Liang Changda, Yang Liangchun, Zhang Hui, Tang Jingyan, Gao Ju, Pui Ching-Hon, Li Chi-Kong

机构信息

Department of Pediatrics, Hong Kong Children's Hospital, The Chinese University of Hong Kong, Hong Kong SAR.

Department of Hematology/Oncology, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Key Laboratory of Pediatric Hematology and Oncology of China Ministry of Health, and National Children's Medical Center, Shanghai.

出版信息

Haematologica. 2024 Aug 1;109(8):2726-2731. doi: 10.3324/haematol.2024.285201.

DOI:10.3324/haematol.2024.285201
PMID:38634141
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11290514/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84bd/11290514/9586dd560f5c/1092726.fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84bd/11290514/9586dd560f5c/1092726.fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84bd/11290514/9586dd560f5c/1092726.fig1.jpg

相似文献

1
Outcome of infants with acute lymphoblastic leukemia treated with the Chinese Children's Cancer Group Acute Lymphoblastic Leukemia 2015 study protocol.采用中国儿童癌症协作组急性淋巴细胞白血病2015研究方案治疗的急性淋巴细胞白血病患儿的治疗结果。
Haematologica. 2024 Aug 1;109(8):2726-2731. doi: 10.3324/haematol.2024.285201.
2
Prognostic value of minimal residual disease measured by flow-cytometry in two cohorts of infants with acute lymphoblastic leukemia treated according to either MLL-Baby or Interfant protocols.采用流式细胞术检测的微小残留病在两组分别按照MLL-婴儿方案或国际儿童急性淋巴细胞白血病研究组（Interfant）方案治疗的急性淋巴细胞白血病婴儿中的预后价值。
Leukemia. 2020 Nov;34(11):3042-3046. doi: 10.1038/s41375-020-0912-z. Epub 2020 Jun 12.
3
[Risk factors for recurrence of childhood acute lymphoblastic leukemia after treatment with the Chinese Children's Cancer Group ALL-2015 protocol].[中国儿童癌症协作组ALL-2015方案治疗后儿童急性淋巴细胞白血病复发的危险因素]
Zhongguo Dang Dai Er Ke Za Zhi. 2024 Jul 15;26(7):701-707. doi: 10.7499/j.issn.1008-8830.2401010.
4
Experience in improving treatment outcomes for childhood acute lymphoblastic leukemia: real-world results for a province in China, 2011-2020.改善儿童急性淋巴细胞白血病治疗结果的经验：中国某省 2011-2020 年的真实结果。
Leuk Lymphoma. 2024 Sep;65(9):1303-1313. doi: 10.1080/10428194.2024.2350665. Epub 2024 May 20.
5
Treatment outcome of young children with acute lymphoblastic leukaemia: achievements and directions implied from Shanghai Children's Medical Centre based SCMC-ALL-2005 protocol.急性淋巴细胞白血病患儿的治疗结局：基于上海儿童医学中心SCMC-ALL-2005方案的成果与启示
Br J Haematol. 2015 Apr;169(2):267-77. doi: 10.1111/bjh.13288. Epub 2015 Feb 5.
6
Should treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia be intensive? Intensive treatment is the best treatment for these patients.费城染色体阳性的急性淋巴细胞白血病的治疗应该强化吗？强化治疗是这些患者的最佳治疗方法。
Clin Adv Hematol Oncol. 2016 Nov;14(11):892-894.
7
Excellent outcomes for adolescents and adults with acute lymphoblastic leukemia and lymphoma without allogeneic stem cell transplant: the FRALLE-93 pediatric protocol.未进行异基因干细胞移植的青少年及成人急性淋巴细胞白血病和淋巴瘤患者的良好预后：FRALLE - 93儿童方案
Leuk Lymphoma. 2014 Dec;55(12):2801-7. doi: 10.3109/10428194.2014.894191. Epub 2014 Mar 19.
8
Outcome of relapsed infant acute lymphoblastic leukemia treated on the interfant-99 protocol.采用Interfant-99方案治疗的复发性婴儿急性淋巴细胞白血病的疗效
Leukemia. 2016 May;30(5):1184-7. doi: 10.1038/leu.2015.246. Epub 2015 Sep 15.
9
Should treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia be intensive? Intensive treatment is not necessary, at least in induction.费城染色体阳性急性淋巴细胞白血病的治疗应该强化吗？强化治疗并非必要，至少在诱导期是这样。
Clin Adv Hematol Oncol. 2016 Nov;14(11):892-896.
10
Challenges of starting treatment protocols for acute lymphoblastic leukaemia in a low-income setting - the Blantyre experience.在低收入环境中启动急性淋巴细胞白血病治疗方案面临的挑战——布兰太尔经验
Br J Haematol. 2020 Nov;191(3):e87-e90. doi: 10.1111/bjh.17040. Epub 2020 Aug 17.

引用本文的文献

1
Case Report: A case of infantile acute hyperleukocytic leukemia treated by leukapheresis.病例报告：1例采用白细胞单采术治疗的婴儿急性高白细胞白血病病例。
Front Pediatr. 2024 Dec 9;12:1497943. doi: 10.3389/fped.2024.1497943. eCollection 2024.

本文引用的文献

1
Blinatumomab Added to Chemotherapy in Infant Lymphoblastic Leukemia.Blinatumomab 联合化疗治疗婴儿急性淋巴细胞白血病。
N Engl J Med. 2023 Apr 27;388(17):1572-1581. doi: 10.1056/NEJMoa2214171.
2
Impact of high-risk cytogenetics on outcomes for children and young adults receiving CD19-directed CAR T-cell therapy.高危细胞遗传学对接受 CD19 靶向 CAR T 细胞治疗的儿童和青少年结局的影响。
Blood. 2022 Apr 7;139(14):2173-2185. doi: 10.1182/blood.2021012727.
3
Pulse therapy with vincristine and dexamethasone for childhood acute lymphoblastic leukaemia (CCCG-ALL-2015): an open-label, multicentre, randomised, phase 3, non-inferiority trial.
长春新碱和地塞米松脉冲疗法治疗儿童急性淋巴细胞白血病（CCCG-ALL-2015）：一项开放标签、多中心、随机、3 期、非劣效性试验。
Lancet Oncol. 2021 Sep;22(9):1322-1332. doi: 10.1016/S1470-2045(21)00328-4. Epub 2021 Jul 27.
4
Lineage Switch in an Infant B-Lymphoblastic Leukemia With t(1;11)(p32;q23); , Following Blinatumomab Therapy.婴儿 B 淋巴细胞白血病伴 t(1;11)(p32;q23); 经blinatumomab 治疗后出现谱系转换。
Pediatr Dev Pathol. 2021 Jul-Aug;24(4):378-382. doi: 10.1177/10935266211001308. Epub 2021 Mar 22.
5
Prognostic factors for CNS control in children with acute lymphoblastic leukemia treated without cranial irradiation.儿童急性淋巴细胞白血病治疗中不进行颅脑照射时的 CNS 控制的预后因素。
Blood. 2021 Jul 29;138(4):331-343. doi: 10.1182/blood.2020010438.
6
FLT3 inhibitor lestaurtinib plus chemotherapy for newly diagnosed KMT2A-rearranged infant acute lymphoblastic leukemia: Children's Oncology Group trial AALL0631.FLT3 抑制剂 lestaurtinib 联合化疗治疗新诊断的 KMT2A 重排婴儿急性淋巴细胞白血病：儿童肿瘤学组试验 AALL0631。
Leukemia. 2021 May;35(5):1279-1290. doi: 10.1038/s41375-021-01177-6. Epub 2021 Feb 23.
7
A risk-stratified therapy for infants with acute lymphoblastic leukemia: a report from the JPLSG MLL-10 trial.分层风险治疗急性淋巴细胞白血病患儿：来自 JPLSG MLL-10 试验的报告。
Blood. 2020 Oct 15;136(16):1813-1823. doi: 10.1182/blood.2019004741.
8
Outcome of Infants Younger Than 1 Year With Acute Lymphoblastic Leukemia Treated With the Interfant-06 Protocol: Results From an International Phase III Randomized Study.《国际多中心 III 期随机研究：婴儿急性淋巴细胞白血病采用 Interfant-06 方案治疗的结局》
J Clin Oncol. 2019 Sep 1;37(25):2246-2256. doi: 10.1200/JCO.19.00261. Epub 2019 Jul 8.
9
CD19 CAR immune pressure induces B-precursor acute lymphoblastic leukaemia lineage switch exposing inherent leukaemic plasticity.CD19 CAR 免疫压力诱导 B 前体细胞急性淋巴细胞白血病谱系转换，揭示内在白血病可塑性。
Nat Commun. 2016 Jul 27;7:12320. doi: 10.1038/ncomms12320.
10
Lineage Switch in MLL-Rearranged Infant Leukemia Following CD19-Directed Therapy.CD19导向治疗后MLL重排婴儿白血病中的谱系转换
Pediatr Blood Cancer. 2016 Jun;63(6):1113-5. doi: 10.1002/pbc.25953. Epub 2016 Feb 23.